Angioimmunoblastic T-cell lymphoma Journal Article

  


Authors: Yabe, M.; Dogan, A.; Horwitz, S. M.; Moskowitz, A. J.
Article Title: Angioimmunoblastic T-cell lymphoma
Abstract: Angioimmunoblastic T-cell lymphoma (AITL) is one of the most common types of T-cell lymphoma, representing about 15–20% of cases of peripheral T-cell lymphoma (PTCL). It is characterized by a unique clinical presentation and distinct pathologic and molecular features. Classes of drugs particularly active in AITL are emerging; however, treatment of relapsed and refractory disease remains a challenge. This chapter reviews the epidemiology, clinical presentation, pathogenesis, diagnosis, and treatment of AITL. © Springer Nature Switzerland AG 2019.
Keywords: treatment; pathology; angioimmunoblastic t-cell lymphoma; follicular helper t-cell
Journal Title: Cancer Treatment and Research
Volume: 176
ISSN: 0927-3042
Publisher: Springer  
Date Published: 2019-01-01
Start Page: 99
End Page: 126
Language: English
DOI: 10.1007/978-3-319-99716-2_5
PUBMED: 30596215
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059289476&doi=10.1007%2f978-3-319-99716-2_5&partnerID=40&md5=5be0551f58a12332e5b4a4a9cc3b8ef1
Notes: Chapter 5 in "T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies" (ISBN: 978-3-319-99715-5) -- Export Date: 1 February 2019 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Steven M Horwitz
    644 Horwitz
  2. Alison Moskowitz
    339 Moskowitz
  3. Ahmet Dogan
    454 Dogan
  4. Mariko Yabe
    50 Yabe
Related MSK Work